These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 26239136

  • 1. miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
    Xu R, Zeng G, Gao J, Ren Y, Zhang Z, Zhang Q, Zhao J, Tao H, Li D.
    Oncol Rep; 2015 Oct; 34(4):2171-8. PubMed ID: 26239136
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells.
    Zeng G, Xun W, Wei K, Yang Y, Shen H.
    Oncol Rep; 2016 Sep; 36(3):1475-82. PubMed ID: 27432214
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
    Wang X, Li GH.
    J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
    [Abstract] [Full Text] [Related]

  • 4. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
    Wang L, Liu H.
    Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
    [Abstract] [Full Text] [Related]

  • 5. Circ-HIPK3 regulates YAP1 expression by sponging miR-381-3p to promote oral squamous cell carcinoma development.
    Bi L, Zhang C, Yao Y, He Z.
    J Biosci; 2021 Mar; 46():. PubMed ID: 33737493
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z, Hao XY, Liu FX.
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [Abstract] [Full Text] [Related]

  • 7. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J, Wen N, Yang S, Guan X, Cang S.
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH, Ma ZH, Wang X.
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z.
    Oncogene; 2014 Oct 16; 33(42):5017-27. PubMed ID: 24141785
    [Abstract] [Full Text] [Related]

  • 10. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
    Hu XH, Dai J, Shang HL, Zhao ZX, Hao YD.
    Cancer Biomark; 2019 Oct 16; 25(1):1-10. PubMed ID: 31006663
    [Abstract] [Full Text] [Related]

  • 11. microRNA-211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein.
    Zheng J, Wang J, Jia Y, Liu T, Duan Y, Liang X, Liu L.
    J Cell Biochem; 2019 Mar 16; 120(3):4644-4653. PubMed ID: 30260023
    [Abstract] [Full Text] [Related]

  • 12. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B.
    Cancer Med; 2017 Dec 16; 6(12):2897-2908. PubMed ID: 29125238
    [Abstract] [Full Text] [Related]

  • 13. Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.
    Hu S, Wang H, Yan D, Lu W, Gao P, Lou W, Kong X.
    Cell Cycle; 2018 Dec 16; 17(18):2284-2295. PubMed ID: 30252587
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X, Gan Q, Gan C, Zheng Y, Cai B, Li X, Li D, Yin G.
    Life Sci; 2021 Jun 01; 274():118303. PubMed ID: 32841663
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
    Chou ST, Peng HY, Mo KC, Hsu YM, Wu GH, Hsiao JR, Lin SF, Wang HD, Shiah SG.
    J Exp Clin Cancer Res; 2019 Jun 28; 38(1):281. PubMed ID: 31253192
    [Abstract] [Full Text] [Related]

  • 16. MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
    Liu C, Wang Z, Wang Y, Gu W.
    Mol Cell Biochem; 2015 Jan 28; 398(1-2):115-22. PubMed ID: 25204970
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2.
    Sun X, Zhang L.
    Biosci Rep; 2017 Jun 30; 37(3):. PubMed ID: 28174335
    [Abstract] [Full Text] [Related]

  • 18. miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.
    Piao L, Wang F, Wang Y, Yang Z, Li Q, Cui L, Yu Q.
    Cancer Biother Radiopharm; 2019 Apr 30; 34(3):196-202. PubMed ID: 30676784
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
    Zhang B, Li Y, Hou D, Shi Q, Yang S, Li Q.
    Cell Physiol Biochem; 2017 Apr 30; 42(5):2105-2117. PubMed ID: 28810236
    [Abstract] [Full Text] [Related]

  • 20. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX, Zhang WL, Yu XH, Wu JS, Qiao XW, Huang MC, Wang K, Wu JB, Tang YJ, Jiang J, Liang XH, Tang YL.
    J Exp Clin Cancer Res; 2020 Jun 03; 39(1):102. PubMed ID: 32493454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.